Form D · Biotechnology
COURAGE THERAPEUTICS, INC.
Newton, MA · CIK 0002069873
Offering snapshot reported May 22, 2025 · SEC filing
- Reported sold
- $4.51M Offering amount: $10.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2025 | Initial | $4,510,963 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546995
Source: Form D, filed May 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Isaac Barchas | Director |
| Roger Cone | Director |
| Daniel Housman | Director, Executive |
| Bruce Leutcher | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
64 Homer Street
Newton, MA, 02459
Newton, MA, 02459